genipin

Small moleculeexperimental

Clinical trial activity

1 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0

Earliest trial started Jun 28, 2016 (NCT05755750)

Timeline

2010s

  1. Jan 1, 2016

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetCROSS-LINKING AGENT

    cross-linking agent

Chemistry & pharmacology

Loading structure…

SMILES

COC(=O)C1=CO[C@@H](O)[C@@H]2C(CO)=CC[C@H]12
Mol. weight
226.23 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05755750Phase 3Jun 28, 2016University of Zurich
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of ZurichAcademic/Hospital1112016
1 organizations
Page 1 / 1